Longitudinal Tracking of Lung Cancer Clonal Dynamics using Circulating Tumour DNA
Thursday, January 28, 2027 at 4:40 PM to 5:10 PM · 30 min. (Europe/London)
Cancer Diagnostics Stage
Day 2 - Thursday 28th January
CancerDiagnosticsLiquid Biopsy
Information
- Cancer dynamics can be accurately tracked using circulating tumour DNA, overcoming limitations of sampling bias associated with biopsies
- We development a method to do this when the fraction of DNA in the blood from the tumour is extremely low (<0.1%), as is common, called ECLIPSE
- ECLIPSE reveals more complex metastatic patterns than previously appreciated, associated with outcome
- ECLIPSE reveals clonal dynamics in response to therapy, which are particularly common in immunotherapy treatment, suggesting as yet undiscovered resistance mechanisms.
